Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine

Intensive Care Medicine Experimental

Volumn 2, Issue 1, 2014, Pages 1-25

  Cain, David J ^a   del Arroyo, Ana Gutierrez ^a   Ackland, Gareth L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Critical care; Human; Immunology; Sepsis; Surgical intensive care

Indexed keywords

EID: 84991219331     PISSN: None     EISSN: 2197425X     Source Type: Journal    
DOI: 10.1186/2197-425X-2-6     Document Type: Article

References (87)

1. Harrison DA, Welch CA, Eddleston JM: The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database.Crit Care 2006, 10:R42.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.Crit Care Med 2007, 35:1244–1250.
3. Ranieri VM, Thompson BT, Barie PS, Dhainaut J-F, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD: Drotrecogin Alfa (activated) in adults with septic shock.N Engl J Med 2012, 366:2055–2064.
4. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre P-F, Reinhart K, Cuthbertson BH, Payen D, Briegel J: Hydrocortisone therapy for patients with septic shock.N Engl J Med 2008, 358:111–124.
5. Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients.N Engl J Med 2009, 360:1283–1297.
6. Mestas J, Hughes CCW: Of mice and not men: differences between mouse and human immunology.J Immunol 2004, 172:2731–2738.
7. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, López MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, et al.: A genomic storm in critically injured humans.J Exp Med 2011, 208:2581–2590.
8. Kanoh S, Rubin BK: Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Clin Microbiol Rev 2010, 23:590–615.
9. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways.Nature 1993, 362:849–852.
10. Mikawa K, Akamatsu H, Maekawa N, Nishina K, Niwa Y: Propofol inhibits human neutrophil functions.Anesth Analg 1998, 87:695–700.
11. White M, Mahon V, Grealy R, Doherty DG, Stordeur P, Kelleher DP, McManus R, Ryan T: Post-operative infection and sepsis in humans is associated with deficient gene expression of γc cytokines and their apoptosis mediators.Crit Care 2011, 15:R158.
12. Santos SS, Brunialti MKC, Rigato O, Machado FR, Silva E, Salomao R: Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes.Shock 2012, 38:18–23.
13. Bruns T, Peter J, Hagel S, Herrmann A, Stallmach A: The augmented neutrophil respiratory burst in response toEscherichia coliis reduced in liver cirrhosis during infection.Clin Exp Immunol 2011, 164:346–356.
14. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salomão R: Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock.Shock 2003, 20:208–212.
15. Barth E, Fischer G, Schneider EM, Moldawer LL, Georgieff M, Weiss M: Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock.Cytokine 2002, 17:275–284.
16. Mariano F, Tetta C, Guida G, Triolo G, Camussi G: Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients.Kidney Int 2001, 60:1598–1605.
17. Ahmed NA, McGill S, Yee J, Hu F, Michel RP, Christou NV: Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis).Crit Care Med 1999, 27:2459–2468.
18. Pascual C, Bredle D, Karzai W, Meier-Hellmann A, Oberhoffer M, Reinhart K: Effect of plasma and LPS on respiratory burst of neutrophils in septic patients.Intensive Care Med 1998, 24:1181–1186.
19. Paunel-Görgülü A, Lögters T, Flohé S, Cinatl J, Altrichter J, Windolf J, Scholz M: Stimulation of Fas signaling down-regulates activity of neutrophils from major trauma patients with SIRS.Immunobiology 2011, 216:334–342.
20. Shih H-C, Huang M-S, Lee C-H: Polymorphonuclear cell priming associated with NF-kB activation in patients with severe injury is partially dependent on macrophage migration inhibitory factor.J Am Coll Surg 2010, 211:791–797.
21. Kasten KR, Goetzman HS, Reid MR, Rasper AM, Adediran SG, Robinson CT, Cave CM, Solomkin JS, Lentsch AB, Johannigman JA, Caldwell CC: Divergent adaptive and innate immunological responses are observed in humans following blunt trauma.BMC Immunol 2010, 11:4.
22. Valente SA, Fallon WF, Alexander TS, Tomas ER, Evancho-Chapman MM, Schmidt SP, Gorski R, Pizov O, DeFine L, Clark AJ: Immunologic function in the elderly after injury–the neutrophil and innate immunity.J Trauma 2009, 67:968–974.
23. Quaid G, Cave C, Williams MA, Hennigan RF, Bokoch G, Solomkin JS: Mechanisms of human neutrophil oxidant production after severe injury.Surgery 2001, 130:669–675. discussion 675–6
24. Ertel W, Keel M, Buergi U, Hartung T, Imhof HG, Trentz O: Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury.J Trauma 1999, 46:784–792. discussion 792–3
25. Ogura H, Tanaka H, Koh T, Hashiguchi N, Kuwagata Y, Hosotsubo H, Shimazu T, Sugimoto H: Priming, second-hit priming, and apoptosis in leukocytes from trauma patients.J Trauma 1999, 46:774–781. discussion 781–3
26. Kawasaki T, Ogata M, Kawasaki C, Okamoto K, Sata T: Effects of epidural anaesthesia on surgical stress-induced immunosuppression during upper abdominal surgery.Br J Anaesth 2007, 98:196–203.
27. Fröhlich D, Trabold B, Rothe G, Hoerauf K, Wittmann S: Inhibition of the neutrophil oxidative response by propofol: preserved in vivo function despite in vitro inhibition.Eur J Anaesthesiol 2006, 23:948–953.
28. Wiezer MJ, Meijer C, Sietses C, Prins HA, Cuesta MA, Beelen RH, Meijer S, van Leeuwen PA: Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection.Ann Surg 2000, 232:208–215.
29. Shih HC, Su CH, Lee CH: Superoxide production of neutrophils after severe injury: impact of subsequent surgery and sepsis.Am J Emerg Med 1999, 17:15–18.
30. Liu TF, Yoza BK, El Gazzar M, Vachharajani VT, McCall CE: NAD + -dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance.J Biol Chem 2011, 286:9856–9864.
31. Pachot A, Cazalis M-A, Venet F, Turrel F, Faudot C, Voirin N, Diasparra J, Bourgoin N, Poitevin F, Mougin B, Lepape A, Monneret G: Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression.J Immunol 2008, 180:6421–6429.
32. West MA, Koons A, Crandall M, Skinner R, Worley M, Shapiro MB: Whole blood leukocyte mitogen activated protein kinases activation differentiates intensive care unit patients with systemic inflammatory response syndrome and sepsis.J Trauma 2007, 62:805–811.
33. Härter L, Mica L, Stocker R, Trentz O, Keel M: Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis.Shock 2004, 22:403–409.
34. Escoll P, del Fresno C, García L, Vallés G, Lendínez MJ, Arnalich F, López-Collazo E: Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients.Biochem Biophys Res Commun 2003, 311:465–472.
35. Calvano JE, Agnese DM, Um JY, Goshima M, Singhal R, Coyle SM, Reddell MT, Kumar A, Calvano SE, Lowry SF: Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.Shock 2003, 20:415–419.
36. Sfeir T, Saha DC, Astiz M, Rackow EC: Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock.Crit Care Med 2001, 29:129–133.
37. Heagy W, Hansen C, Nieman K, Cohen M, Richardson C, Rodriguez JL, West MA: Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify “septic” intensive care unit patients.Shock 2000, 14:271–276. discussion 276–7
38. Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlböck M, Roth E, Függer R: Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis.Shock 1999, 12:421–427.
39. Heagy W, Nieman K, Hansen C, Cohen M, Danielson D, West MA: Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients.Surg Infect (Larchmt) 2003, 4:171–180.
40. Flohé S, Lendemans S, Schade F-U, Kreuzfelder E, Waydhas C: Influence of surgical intervention in the immune response of severely injured patients.Intensive Care Med 2004, 30:96–102.
41. Buttenschoen K, Schneider ME, Utz K, Kornmann M, Beger HG, Carli Buttenschoen D: Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4.Langenbecks Arch Surg 2009, 394:293–302.
42. Kawasaki T, Ogata M, Kawasaki C, Tomihisa T, Okamoto K, Shigematsu A: Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery.Anesth Analg 2001, 92:1322–1326.
43. Roger P-M, Hyvernat H, Ticchioni M, Kumar G, Dellamonica J, Bernardin G: The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells.J Crit Care 2012, 27:384–393.
44. Zhang Y, Li J, Lou J, Zhou Y, Bo L, Zhu J, Zhu K, Wan X, Cai Z, Deng X: Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.Crit Care 2011, 15:R70.
45. Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Chéron A, Allaouchiche B, Gueyffier F, Ayala A, Monneret G, Venet F: Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.Crit Care 2011, 15:R99.
46. Vaki I, Kranidioti H, Karagianni V, Spyridaki A, Kotsaki A, Routsi C, Giamarellos-Bourboulis EJ: An early circulating factor in severe sepsis modulates apoptosis of monocytes and lymphocytes.J Leukoc Biol 2011, 89:343–349.
47. Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al.: Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection.Crit Care 2010, 14:R96.
48. Hoogerwerf JJ, van Zoelen MA, Wiersinga WJ, van’t Veer C, de Vos AF, de Boer A, Schultz MJ, Hooibrink B, de Jonge E, van derPoll T: Gene expression profiling of apoptosis regulators in patients with sepsis.J Innate Immun 2010, 2:461–468.
49. Yousef AA, Suliman GA, Mabrouk MM: The value of correlation of serum 20S proteasome concentration and percentage of lymphocytic apoptosis in critically ill patients: a prospective observational study.Crit Care 2010, 14:R215.
50. Turrel-Davin F, Guignant C, Lepape A, Mougin B, Monneret G, Venet F: Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients.Crit Care 2010, 14:R133.
51. Pelekanou A, Tsangaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A, Giamarellos-Bourboulis EJ: Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study.Crit Care 2009, 13:R172.
52. Delogu G, Famularo G, Tellan G, Marandola M, Antonucci A, Signore M, Marcellini S, Moretti S: Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock.Infection 2008, 36:485–487.
53. Weber SU, Schewe J, Lehmann LE, Müller S, Book M, Klaschik S, Hoeft A, Stüber F: Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. 12:1–10.Crit Care 2008,12(5):R128.
54. Roth G, Moser B, Krenn C, Brunner M, Haisjackl M, Almer G, Gerlitz S, Wolner E, Boltz-Nitulescu G, Ankersmit HJ: Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance.Biochem Biophys Res Commun 2003, 308:840–846.
55. Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R, Drénou B: Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome.Shock 2002, 18:487–494.
56. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, Karl IE: Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.J Immunol 2001, 166:6952–6963.
57. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction.Crit Care Med 1999, 27:1230–1251.
58. Bandyopadhyay G, Bankey PE, Miller-Graziano CL: Trauma patients’ elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis.Clin Immunol 2012, 145:44–54.
59. Pellegrini JD, De AK, Kodys K, Puyana JC, Furse RK, Miller-Graziano C: Relationships between T lymphocyte apoptosis and anergy following trauma.J Surg Res 2000, 88:200–206.
60. Hotchkiss RS, Schmieg RE, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Karl IE, Buchman TG: Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock.Crit Care Med 2000, 28:3207–3217.
61. Papadima A, Boutsikou M, Lagoudianakis EE, Kataki A, Konstadoulakis M, Georgiou L, Katergiannakis V, Manouras A: Lymphocyte apoptosis after major abdominal surgery is not influenced by anesthetic technique: a comparative study of general anesthesia versus combined general and epidural analgesia.J Clin Anesth 2009, 21:414–421.
62. Słotwiński R, Olszewski W, Słodkowski M, Lech G, Zaleska M, Kędziora S, Włuka A, Domaszewska A, Słotwińska S, Krasnodębski W, Wójcik Z: Apoptosis in lymphocytes of pancreatic cancer patients: influence of preoperative enteral immunonutrition and extensive surgery.Arch Immunol Ther Exp (Warsz) 2011, 59:385–397.
63. Delogu G, Famularo G, Moretti S, De Luca A, Tellan G, Antonucci A, Marandola M, Signore L: Interleukin-10 and apoptotic death of circulating lymphocytes in surgical/anesthesia trauma.J Trauma 2001, 51:92–97.
64. Delogu G, Moretti S, Antonucci A, Marcellini S, Masciangelo R, Famularo G, Signore L, De Simone C: Apoptosis and surgical trauma: dysregulated expression of death and survival factors on peripheral lymphocytes.Arch Surg 2000, 135:1141–1147.
65. Sasajima K, Inokuchi K, Onda M, Miyashita M, Okawa KI, Matsutani T, Takubo K: Detection of T cell apoptosis after major operations.Eur J Surg 1999, 165:1020–1023.
66. Sugimoto M, Shimaoka M, Hosotsubo K, Tanigami H, Taenaka N, Kiyono H, Yoshiya I: Up-regulation of Fas ligand (FasL) mRNA expression in peripheral blood mononuclear cells (PBMC) after major surgery.Clin Exp Immunol 1998, 112:120–125.
67. Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K: Causes, consequences, and reversal of immune system aging.J Clin Invest 2013, 123:958–965.
68. Frink M, Pape H-C, van Griensven M, Krettek C, Chaudry IH, Hildebrand F: Influence of sex and age on mods and cytokines after multiple injuries.Shock 2007, 27:151–156.
69. Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni S, Fiore G, Filippini C, Ranieri V: The influence of gender on the epidemiology of and outcome from severe sepsis.Crit Care 2013, 17:R50.
70. Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, Angus DC: Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis.JAMA 2010, 303:2495–2503.
71. Fildes JE, Shaw SM, Yonan N, Williams SG: The immune system and chronic heart failure: is the heart in control?J Am Coll Cardiol 2009, 53:1013–1020.
72. Schreiber RD, Old LJ, Smyth MJ: Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion.Science 2011, 331:1565–1570.
73. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest 1992, 101:1644–1655.
74. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med 2003, 31:1250–1256.
75. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut J-F, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent J-L: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.Intensive Care Med 2008, 34:17–60.
76. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury.Nature 2010, 464:104–107.
77. Menu P, Vince JE: The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.Clin Exp Immunol 2011, 166:1–15.
78. Vandenesch F, Lina G, Henry T: Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?Front Cell Infect Microbiol 2012, 2:12.
79. Kanoh S, Rubin BK: Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Clin Microbiol Rev 2010, 23:590–615.
80. Mikawa K, Akamatsu H, Maekawa N, Nishina K, Niwa Y: Propofol inhibits human neutrophil.Anesth Analg 1998, 87:695–700.
81. Vallejo R, de Leon-Casasola O, Benyamin R: Opioid therapy and immunosuppression: a review.Am J Ther 2004, 11:354–365.
82. Lawson EH, Louie R, Zingmond DS, Brook RH, Hall BL, Han L, Rapp M, Ko CY: A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications.Ann Surg 2012, 256:973–981.
83. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system.Crit Care Med 1985, 13:818–829.
84. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.Chest 1991, 100:1619–1636.
85. ASA Physical Status Classification System. http://www.asahq.org/For-Members/Clinical-Information/ASA-Physical-Status-Classification-System.aspx. Accessed 27 Jun 2013
86. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988.Am Rev Respir Dis 1989, 139:1058–1059.
87. Baker SP, O’Neill B, Haddon W, Long WB: The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care.J Trauma 1974, 14:187–196.